ImmunoGraft® platform for the evaluation of Immuno-Oncology agents in PDX tumors models

被引：0
|
作者：
Cerna, David
Ciznadija, Daniel
Verma, Bhavna
Sidransky, David
Izumchenko, Evgeny
Davies, Angela
Mancini, Maria
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1648
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1648
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Implementation of a Clinical Immuno-Oncology Panel for Pediatric Brain Tumors
    Levine, A.
    Das, A.
    Hawkins, C.
    Johnson, M.
    Laxer, B.
    Milos, S.
    Nobre, L.
    Ryall, S.
    Siddaway, R.
    Tabori, U.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S129 - S129
  • [32] Renaissance of immuno-oncology for urological tumors. Current status
    Grimm, M. -O.
    Winkler, Y.
    Fetter, I.
    Oppel-Heuchel, H.
    UROLOGE, 2016, 55 (05): : 621 - 626
  • [33] Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment
    Chiorazzi, Michael
    Martinek, Jan
    Krasnick, Bradley
    Zheng, Yunjiang
    Robbins, Keenan J.
    Qu, Rihao
    Kaufmann, Gabriel
    Skidmore, Zachary
    Juric, Melani
    Henze, Laura A.
    Brosecke, Frederic
    Adonyi, Adam
    Zhao, Jun
    Shan, Liang
    Sefik, Esen
    Mudd, Jacqueline
    Bi, Ye
    Goedegebuure, S. Peter
    Griffith, Malachi
    Griffith, Obi
    Oyedeji, Abimbola
    Fertuzinhos, Sofia
    Garcia-Milian, Rolando
    Boffa, Daniel
    Detterbeck, Frank
    Dhanasopon, Andrew
    Blasberg, Justin
    Judson, Benjamin
    Gettinger, Scott
    Politi, Katerina
    Kluger, Yuval
    Palucka, Karolina
    Fields, Ryan C.
    Flavell, Richard A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (07)
  • [34] Platform Phase I Study Investigating the Safety of Multisite Stereotactic Body Radiotherapy with Immuno-Oncology Agents for the Treatment of Metastatic Advanced Solid Tumors
    Foster, C. C.
    Luke, J. J.
    Chmura, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1193 - 1193
  • [35] Development and validation of a screening platform for the identification of novel immuno-oncology targets
    Scoumanne, Ariane
    Rabolli, Virginie
    Legrand, Lea
    Martini, Murielle
    Letellier, Marie-Claire
    Crosignani, Stefano
    Queva, Christophe
    Detheux, Michel
    Cauwenberghs, Sandra
    Swiercz, Jakub
    CANCER RESEARCH, 2017, 77
  • [36] Organotypic tumor tissue slices provide versatile platform for immuno-oncology
    Sivakumar, Ramya
    Chan, Marina
    Yeung, Raymond
    Gujral, Taranjit S.
    CANCER RESEARCH, 2019, 79 (13)
  • [37] Immuno-oncology trends: preclinical models, biomarkers, and clinical development
    Franklin, Maryland Rosenfeld
    Platero, Suso
    Saini, Kamal S.
    Curigliano, Giuseppe
    Anderson, Steven
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [38] The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives
    Sancho-Araiz, Aymara
    Mangas-Sanjuan, Victor
    Troconiz, Inaki F.
    PHARMACEUTICS, 2021, 13 (07)
  • [39] The immuno-AVI-PDX, am innovative patient-derived xenograft model for preclinical immuno-oncology studies
    Lacourrege, Marjorie
    Costechareyre, Clelia
    Jarrosson, Loraine
    Teinturier, Romain
    Berget, Frederic
    Delloye-Bourgeois, Celine
    Castellani, Valerie
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Novel prostate cancer models for immuno-oncology and immunotherapy research
    Marques, R. Barbosa
    van Gelder, M.
    van Duijn, P.
    de Ridder, C.
    Trapman, J.
    Debets, R.
    van Weerden, W.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E100 - E100
12345